Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
In patients with progressive fibrosing interstitial lung diseases, the annual rate of decline in the FVC was significantly lower among patients who received nintedanib than amon...
Publications
View AllAffiliated Researchers
Institution Info
- Type
- company
- Country
- BE
- Publications
- 1
- Citations
- 2,097
External Links
Identifiers
- ROR
- https://ror.org/0324red69